Has Manuel Pinto, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,669,386 in general payments to Manuel Pinto, MD across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manuel Pinto, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manuel Pinto, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manuel Pinto, MD

Orthopaedic Surgery · Minneapolis, MNNPI 1770521114

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,639,329 of the $1,669,386 with a category attached, or 98.2%. Medtronic accounts for 95.2% of it on its own, with 7 other manufacturers making up the rest. Among orthopaedic surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,669,386in general payments, 2019–2025

Across 129 payments — averaging $12,941 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$1.6M
Globus Medical$79K
Arthrex$987
Foundation Medical, LLC$242
Cerapedics Inc.$130
Intrinsic Therapeutics$85
plus $60 from 2 others

$3,000in research payments, 2019–2025

Across 10 payments — averaging $300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intrinsic Therapeutics$3K

What the payments were for

Royalty or licence$1,639,32998%
Consulting fees$24,6561%
Travel & lodging$3,3390%
Food & beverage$1,9320%
Education$1300%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	39	$1,589,283
Globus Medical	60	$78,600
Arthrex	10	$987
Foundation Medical, LLC	5	$242
Cerapedics Inc.	12	$130
Intrinsic Therapeutics	1	$85
Si-bone, Inc.	1	$40
Carlsmed, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CD HORIZON SPINAL SYSTEM$899,967
CD HORIZON$687,950
Plymouth$30,168
Graft Delivery$24,656
InstaFill$21,231
MARS 3VL Retractor$873
RISE-L$857
Quartex$492
CLYDESDALE$304
Excelsius - GPS$209
ENDOSKELETON TL NANOLOCK SURFACE TECHNOLOGY$173
ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$167
MAZOR X SYSTEM$164
MazorX - Renaissance$150
UNID_PASS$139
Adaptix$137
CLYDESDALE PTC SPINAL SYSTEM$110

How this compares

$1,669,386 in reported general payments places this provider in the 95th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024

$314,107

Medicare patients

241

Services billed

1,053

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisone	78	$574
Gabapentin	55	$483
Methylprednisolone	52	$363
Tramadol Hcl	72	$202
Cyclobenzaprine Hcl	29	$150
Pregabalin	15	$110
Acetaminophen-CodeineAcetaminophen With Codeine	17	$96
Meloxicam	20	$54

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Minneapolis

David PollyMinneapolis$3.3M
Ensor TransfeldtMinneapolis$2.3M
Joseph PerraMinneapolis$1.6M
Timothy GarveyMinneapolis$1.6M
Amir MehbodMinneapolis$1.3M
David TemplemanMinneapolis$361K
Patrick YoonMinneapolis$203K
Christopher MartinMinneapolis$131K
Elizabeth ArendtMinneapolis$111K
Emily WagstromMinneapolis$71K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →